Impact of ribociclib (RIB) dose reduction on overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) in MONALEESA (ML)-3 and-7
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
De Laurentiis, M.
Merino, L. de la Cruz
Hart, L.
Bardia, A.
Im, S-A.
Sohn, J.
Neven, P.
Martin, M.
Ji, Y.
Yang, S.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
